10-Q: Avant Technologies Narrows Loss Amid Going Concern Doubt

Avant Technologies Inc. reported a reduced net loss for Q1 2026, but faces significant liquidity challenges and a going concern doubt, relying on future capital raises for operations.

Summary

• Avant Technologies Inc. (formerly Trend Innovations Holding Inc.) is a technology company focused on AI, full-stack software development, database management, data integration, project management, and cloud services.
• The company reported no revenue for the three months ended June 30, 2025, and June 30, 2024.
• Net loss for the three months ended June 30, 2025, was $487,589, an 8% decrease from $528,843 for the same period in 2024.
• Total operating expenses decreased by 6% to $487,589 for the three months ended June 30, 2025, from $517,294 in the prior year period, primarily due to lower consulting services.
• Cash and cash equivalents significantly decreased to $10,062 as of June 30, 2025, from $81,053 as of March 31, 2025.
• The company's working capital deficit increased to $2,116,555 as of June 30, 2025, from $1,695,484 as of March 31, 2025.
• Total liabilities increased to $2,136,767 as of June 30, 2025, from $1,788,617 as of March 31, 2025.
• Stockholders deficit worsened to $(1,991,461) as of June 30, 2025, from $(1,563,872) as of March 31, 2025.
• Net cash used in operating activities increased substantially to $(240,343) for the three months ended June 30, 2025, compared to $(12,702) for the same period in 2024.
• The company's independent auditors included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern.
• The company terminated its Equity Financing Agreement with GHS Investments, LLC for up to $20,000,000 and withdrew its related Form S-1 registration statement, citing a misalignment of terms with revised business objectives.
• New promissory notes totaling $470,550 were issued to RED ROAD HOLDINGS CORPORATION, Boot Capital LLC, and Vanquish Funding Group Inc. in late 2024 and Q2 2025, with default interest rates of 22% per annum.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to the severe going concern risk, zero revenue, rapidly depleting cash, increasing liabilities, and a significant working capital deficit. While management is pursuing new financing, the termination of a prior agreement and reliance on high-interest debt highlight the precarious financial situation. The reduction in net loss is minor compared to the overall financial distress.

Positives

• Net loss decreased by 8% to $487,589 for the three months ended June 30, 2025, compared to $528,843 for the same period in 2024.
• Total operating expenses decreased by 6% ($29,705) due to lower consulting services and other expenses.
• Increased net cash provided by financing activities to $169,352 for the three months ended June 30, 2025, from $12,865 in the prior year period.
• Strategic joint venture with Ainnova Tech Inc. to develop healthcare AI solutions, with Avant Technologies committing up to $20,000,000 in capital over the next twelve months.
• Management is actively pursuing a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share, after terminating a previous agreement.

Negatives

• The company generated no revenue for the three months ended June 30, 2025, and June 30, 2024.
• Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and insufficient revenue to cover operating costs.
• Cash and cash equivalents significantly decreased to $10,062 as of June 30, 2025, from $81,053 as of March 31, 2025.
• Working capital deficit increased to $2,116,555 as of June 30, 2025, from $1,695,484 as of March 31, 2025.
• Total liabilities increased to $2,136,767 as of June 30, 2025, from $1,788,617 as of March 31, 2025.
• Net cash used in operating activities increased significantly to $240,343 for the three months ended June 30, 2025, indicating higher cash burn.
• Disclosure controls and procedures were deemed not effective as of June 30, 2025, due to lack of resources and reliance on outside consultants.
• The company has an accumulated deficit of $4,606,099 as of June 30, 2025.
• Reliance on debt financing, including new promissory notes with a 22% default interest rate, indicates high-cost capital acquisition.

Risks

• Limited operating history in an evolving industry makes it difficult to evaluate future prospects and increases the risk of not being successful.
• Inability to accurately forecast revenues and plan operating expenses, successfully expand the business, or assimilate acquisitions.
• Failure to adapt to rapidly evolving technology trends or avoid interruptions in product/service offerings.
• Difficulty developing a scalable, high-performance technology infrastructure.
• Challenges in hiring, integrating, and retaining talented personnel, and effectively managing rapid growth.
• Continued net losses and increasing working capital deficiency are expected, with no assurance of achieving profitability.
• Inability to generate positive cash flow from operations, which could adversely affect the business and force suspension or discontinuation of operations.
• Requirement for additional capital to support business growth, which might not be available on acceptable terms, if at all.
• Future issuances of equity or convertible debt securities could result in significant dilution for existing stockholders.
• Any future debt financing may involve restrictive covenants.
• Dependence on key personnel and the need for additional personnel, with the loss of qualified individuals materially affecting business operations.
• Business requires substantial capital, and inadequate cash flows could harm revenues, profitability, and financial condition.
• Limited public market for common stock (OTC QB) may lead to significant volatility and difficulty selling shares.
• Failure to maintain an effective system of internal controls could lead to inaccurate financial reporting or fraud, harming business and stock price.
• Inability to commercialize acquired technologies (Avant! AI, InstantFAME) despite significant investment.
• Termination of the Wired4Health Asset Purchase Agreement, indicating potential issues with strategic acquisitions.
• Absence of a formal enterprise risk management program and a cybersecurity subcommittee on the board increases potential exposure.
• High dependence on equity/debt issuance, which may be dilutive, carry high interest, or impose restrictive covenants.
• Stock price and trading volume may be volatile, unrelated to operating performance.
• No plans to pay cash dividends in the foreseeable future.
• Shares eligible for future sale may adversely affect the market for common stock.
• Charter documents and Nevada law may inhibit a takeover that stockholders consider favorable.
• Limitations on director/officer liability may limit shareholder rights to recover against directors for breach of fiduciary duty.
• Penny stock regulations may impose restrictions on the marketability of securities, affecting liquidity and price.
• FINRA sales practice requirements may limit a stockholder's ability to buy and sell the stock.

Future Outlook

The company anticipates being dependent on additional investment capital to fund operating expenses for the near future. It intends to position itself to raise additional funds through capital markets and expects to have sufficient capital to maintain operations through 2025/2026. To fully implement its business plan, the company needs to raise approximately $10,000,000. Following the termination of a previous equity financing agreement, the company plans to pursue a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share, designed to better reflect market conditions and enhance corporate governance.

Management Comments

• "In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented."
• "Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses."
• "The Company intends to position itself so that it will be able to raise additional funds through the capital markets."
• "Our management is developing plans to alleviate the negative trends and conditions described above."
• "We intend to increase managements review of our financials."
• "The Company determined that the terms of the ELOC, including the existing minimum floor price, no longer align with its revised business objectives and shareholder interests."
• "This new structure will be designed to better reflect prevailing market conditions, enhance compliance with applicable regulations, and support transparent corporate governance."

Industry Context

Avant Technologies operates in the rapidly evolving artificial intelligence and information technology consulting sectors. Its focus on unsupervised learning and healthcare AI (through the Ainnova Tech JV) positions it in high-growth, high-innovation areas. However, the company's lack of revenue and significant financial deficits contrast sharply with the capital-intensive nature and competitive landscape of the AI industry, where substantial investment is typically required for R&D and market penetration. The termination of the Wired4Health acquisition and the GHS financing agreement suggests challenges in executing strategic growth initiatives within this dynamic environment.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Not currently a party to any legal proceedings, and not aware of any pending or potential legal actions.

Related Party Transactions

• Loan from Secretary Natalija Tunevic: $114,328 as of June 30, 2025 (unsecured, non-interest bearing, due on demand).
• Loan from Director Vitalis Racius: $127,983 as of June 30, 2025, with $15,463 advanced during the quarter (unsecured, non-interest bearing, due on demand).
• Loan from Shareholder Marieta Seiranova: $7,000 as of June 30, 2025, with $7,000 advanced during the quarter (unsecured, non-interest bearing, due on demand).
• Loan from Shareholder Mehrabian Investments LLC: $30,000 as of June 30, 2025 (unsecured, non-interest bearing, due on demand).
• Loan from Shareholder IGOR 1 CORP: $227,990 as of June 30, 2025, with $110,710 advanced and $13,357 repaid during the quarter (unsecured, non-interest bearing, due on demand).
• Advances to subsidiary Thynews Tech LLC from related parties: $124,590 as of June 30, 2025 (interest-free, due on demand).
• Natalija Tunevic assigned $229,500 of her accrued loans to third parties with conversion clauses into common stock.
• Mrs. Tunevic wrote off $114,600 salary debt on August 17, 2023, convertible into 9,550,000 common shares.
• Debt Forgiveness Agreements on January 1, 2025, with William Hisey ($5,869.86), Kenneth L Waggoner ($161,739.13), Percy Kwong ($300,000), and Danny Rittman ($375,000).

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from future equity offerings and convertible debt conversions. The limited public market (OTC QB) and potential for high stock price volatility make it difficult to sell shares or realize a fair price. The going concern doubt poses a substantial risk to the value of their investment.
• **Employees/Consultants**: Some compensation is paid in common stock, and past payroll debt has been converted into shares or forgiven, indicating reliance on equity for compensation due to cash constraints. This could affect morale and retention if stock value declines.
• **Creditors**: New promissory notes carry a high default interest rate (22%), indicating increased risk for lenders. Related party loans are unsecured, non-interest bearing, and due on demand, suggesting a reliance on insider funding which may not be sustainable.
• **Customers**: The company's financial instability and ineffective internal controls could impact its ability to deliver and support its technology solutions, potentially affecting customer satisfaction and retention, though no direct impact is stated.

Next Steps

• Position the company to raise additional funds through capital markets.
• Pursue a revised equity financing structure with improved terms, including a higher minimum floor price of $2 per share.
• Increase management's review of financials to address ineffective disclosure controls and procedures.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by zero revenue, rapidly depleting cash reserves ($10,062), a substantial and increasing working capital deficit ($2.1 million), and a worsening stockholders' deficit. The explicit 'going concern' doubt from auditors is a critical red flag. While management is pursuing new financing, the termination of a prior $20 million equity agreement and reliance on high-interest (22% default rate) promissory notes indicate significant challenges in securing capital on favorable terms. The ineffective disclosure controls and procedures further undermine confidence. Given the lack of a viable revenue stream, high cash burn from operations, and precarious financial position, the risk of significant capital loss is extremely high, making it an unsuitable investment.

Keywords

Artificial Intelligence, AI, Technology, Software Development, Healthcare AI, SEC Filing, 10-Q, Financial Reporting, Corporate Governance, Risk Management, AVAI, OTC Markets, Going Concern, Capital Raise